Eurocell plc Transaction in Own Shares

RNS Number : 6817K

Eurocell plc

16 April 2024

 

EUROCELL PLC

("Eurocell" or the "Company")

 

Transaction in Own Shares

 

Eurocell announces that it has purchased (through Peel Hunt LLP acting as the Company's broker) the following number of its ordinary shares of 0.1p each on the London Stock Exchange. The purchased shares will be cancelled.

Date of purchase:	15/04/2024
Number of ordinary shares purchased (aggregated volume):	77,379
Highest price paid per share (pence):	130.00
Lowest price paid per share (pence):	130.00
Volume weighted average price paid per share (pence):	130.00

 

Following the purchase and cancellation of these shares, the Company will have 642,000 shares held in treasury and the Company's issued share capital (excluding shares held as treasury shares) will consist of 109,569,939 shares.

The total number of voting rights in Eurocell is therefore 109,569,939. This figure may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest, or a change to their interest, in the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Peel Hunt as part of the Share Buyback Programme.

Aggregate information:

Venue	Volume-weighted average price (pence per share)	Aggregated volume
XLON	130.00	77,379

 

Individual transactions:

Number of shares purchased	Transaction price (pence per share)	Time of transaction	Venue
50,000	130.00	08:56	XLON
27,379	130.00	10:04	XLON

 

Enquiries:

 

Eurocell plc

Paul Walker

Group Company Secretary

Tel: [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

POSZZGMDKKFGDZM